The Spectroscopy Study of the Binding of an Active Ingredient of Dioscorea Species with Bovine Serum Albumin with or without Co2+ or Zn2+

Bian, He-Dong; Peng, Xia-Lian; Huang, Fu-Ping; Yao, Di; Yu, Qing; Liang, Hong

doi:https://doi.org/10.1155/2014/247595

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusions Acknowledgments References Copyright Related Articles

Special Issue

Chemical Basis of Traditional Medicines and New Potential Applications

View this Special Issue

Research Article | Open Access

Volume 2014 | Article ID 247595 | https://doi.org/10.1155/2014/247595

The Spectroscopy Study of the Binding of an Active Ingredient of Dioscorea Species with Bovine Serum Albumin with or without Co²⁺ or Zn²⁺

He-Dong Bian,^1,2Xia-Lian Peng,²Fu-Ping Huang,²Di Yao,²Qing Yu,²and Hong Liang²

Academic Editor: Shi-Biao Wu

Received30 Mar 2014

Revised06 May 2014

Accepted15 May 2014

Published04 Jun 2014

Abstract

Diosgenin (DIO) is the active ingredient of Dioscorea species. The interaction of DIO with bovine serum albumin (BSA) was investigated through spectroscopic methods under simulated physiological conditions. The fluorescence quenching data revealed that the binding of DIO to BSA without or with Co²⁺ or Zn²⁺ was a static quenching process. The presence of Co²⁺ or Zn²⁺ both increased the static quenching constants K_SV and the binding affinity for the BSA-DIO system. In the sight of the competitive experiment and the negative values of ΔH⁰ and ΔS⁰, DIO bound to site I of BSA mainly through the hydrogen bond and Van der Waals’ force. In addition, the conformational changes of BSA were studied by Raman spectra, which revealed that the secondary structure of BSA and microenvironment of the aromatic residues were changed by DIO. The Raman spectra analysis indicated that the changes of conformations, disulfide bridges, and the microenvironment of Tyr, Trp residues of BSA induced by DIO with Co²⁺ or Zn²⁺ were different from that without Co²⁺ or Zn²⁺.

1. Introduction

Dioscoreaceae mainly distributes Guangdong, Sichuan, and Zhejiang provinces in China. Diosgenin (DIO), 3β-hydroxy-5-spirostene (Figure 1), one of the active ingredients of Dioscorea species, is derived from the tubers of Dioscorea species. The previous studies have indicated that DIO can retard the progression of osteoporosis [1] and attenuate plasma cholesterol [2], possess anti-inflammatory [3] and inhibition of vasoconstriction [4] effects, and so on.

Serum albumin (SA) is composed of three structurally homologous domains (I–III); each domain contains two subdomains (A and B). It is the major transport protein, which can act as a carrier of endogenous and exogenous ligands [5]. The transportation and distribution of the drugs in vivo are related to their interaction with serum albumin. On the other hand, the binding of drugs also can change the conformation function of serum albumin. So it is important to investigate the interaction between drugs and serum albumin. Bovine serum albumin (BSA) has similar structure and property with human serum albumin (HSA); the major difference between these two serum albumins was that there was only one Trp residue in HSA, but in BSA there were two Trp residues (¹³⁴Trp and ²¹²Trp). Compared with HSA, BSA was always selected as a model protein due to its low cost, unusual ligand-binding properties. The study of the interaction between drugs and BSA plays an important role in pharmacology and pharmacodynamics [6].

Blood plasma contains many metal ions which play important roles in the biochemical processes. The previous reports of interactions between serum albumin and several metal ions suggested that many metal ions have special binding sites on proteins [7–9]. The binding of drugs with serum albumin in the presence of metal ions was also extensively studied [10, 11]. The previous studies indicated that the presence of metal ions would not only affect the interaction of serum albumin with drugs, but also the conformational changes of serum albumin induced by drugs. The metal ions of Co²⁺ and Zn²⁺ are abundant essential elements in organism which possess many biochemical functions. It is necessary to investigate the interaction of BSA-DIO in the presence of Co²⁺ or Zn²⁺.

In this paper, we studied the binding of DIO with BSA under simulated physiological conditions of pH = 7.43. Fluorescence spectra and Raman spectra were employed to investigate the binding process and the changes of protein structure in the absence and presence of Co²⁺ or Zn²⁺.

2. Materials and Methods

2.1. Materials

DIO (98%, purchased from Aladdin Reagent Company) was dissolved in ethanol to prepare a stock solution of 1 × 10⁻³ mol·L⁻¹. 0.05 mol·L⁻¹ phosphate buffer solution (PBS) of pH = 7.43, contained 0.1 mol·L⁻¹ NaCl. BSA (98%, fatty acid free, and globulin free, Sigma) was dissolved in PBS to prepare stock solution of 1 × 10⁻³ mol·L⁻¹ and stored at 277 K, diluted before used. Ibuprofen and ketoprofen were dissolved in ethanol to prepare stock solution of 1 × 10⁻³ mol·L⁻¹, respectively. Sodium chloride, ethanol, zinc chloride, cobalt(II) chloride hexahydrate, and other experimental drugs are analytically pure reagents. Double distilled water was used throughout.

2.2. Fluorescence Spectrum

Fluorescence spectra were carried out on a RF-5301 fluorescence spectrophotometer (Japan Shimadzu Company). A solution of 5.0 × 10⁻⁷ mol·L⁻¹ BSA was added in a 1.0 cm quartz cell; metal ions or DIO were then gradually added into BSA by microinjector. Scan the solution of BSA in the absence and presence of DIO or metal ions in the wavelength range of 300–500 nm, respectively. The slit widths were 5 nm/5 nm; the excitation wavelength was 280 nm. The reaction temperatures for DIO-BSA system without metal ions were controlled at 291 K, 298 K, and 306 K, respectively. The reaction temperatures for DIO-BSA system with Co²⁺ or Zn²⁺ were controlled at 298 K. For site marker experiment, BSA and site markers were mixed in equimolar concentrations at room temperature for 2 h, and then DIO was gradually added into the solution, scan the fluorescence spectra of the solution.

2.2.1. The Quenching Mechanism

In order to confirm the quenching mechanism induced by DIO, the fluorescence quenching was described by Stern-Volmer equation [12]: where and are the fluorescence intensity in the absence and presence of quencher, respectively. is the quenching rate constant. is the average fluorescence lifetime of the biomolecule in the absence of quencher. [] is the concentration of quencher. is the Stern-Volmer quenching constant. Since the fluorescence lifetime of the biopolymer is 10⁻⁸ s [13], and can be obtained according to the slopes of the Stern-Volmer plots.

2.2.2. The Quenching Mechanism and the Binding Constant

The binding constants of the static quenching were calculated according to the modified Stern-Volmer equation [14]: where is the fraction of accessible fluorescence and is the effective quenching constant for the accessible fluorophores, which are analogous to associative binding constants.

2.2.3. Thermodynamic Parameters

The enthalpy change () was regarded as a constant when the temperature changed little, then enthalpy change () and entropy change () can be obtained from Van’t Hoff equation [15]: where was the gas constant and was the standard free energy change.

2.2.4. Energy Transfer Calculation

According to Forster’s nonradiative energy transfer theory [16, 17], the energy transfer efficiency is decided not only by the distance between the acceptor and donor, but also the critical energy transfer distance (); that is [18], where is the distance between acceptor and donor and is the critical distance in the case of the transfer efficiency is 50% where is the spatial orientation factor of the dipole, is the refractive index of the medium, is the fluorescence quantum yield of donor, and is the overlap integral of fluorescence emission spectrum of donor and absorption spectrum of acceptor where () is the fluorescence intensity of the donor at wavelength and is the molar absorption coefficient of the acceptor at wavelength .

2.3. Raman Spectrum

The Raman spectra were recorded on a Renishaw Invia+Plus FT-Raman spectrometer using an Ar⁺ laser with excitation wavelength of 514 nm. The laser power was 3 mW; the recording range was 200–2000 cm⁻¹ with spectral resolution of 1 cm⁻¹. Scan the Raman spectra of 5 × 10⁻⁴ mol·L⁻¹ BSA in the absence and presence of DIO and metal ions of the same concentration under the room temperature. In Raman experiment, DIO was first dissolved in ethanol/water (1 : 9) and then mixed with BSA, metal ions solution to prepare Raman scanning sample. The curve fitting of Raman spectral regions was analysed by the curve-fitting procedure (Peak Analyzer module of Origin 8.0, Microcal Origin, USA) using Gaussian curves.

3. Results and Discussion

3.1. The Influence of DIO on the Fluorescence of BSA without or with Co²⁺ or Zn²⁺

For macromolecules, the fluorescence measurements can give information of the binding of small molecule substances to protein. When excited at 280 nm, the intrinsic fluorescence of BSA was mainly contributed by Trp residues [19, 20]. The fluorescence of BSA quenched by DIO in the presence and absence of Co²⁺ or Zn²⁺ of the same concentration was shown in Figure 2. Figure 2(a) showed that the fluorescence intensity of BSA decreased regularly with increasing DIO. Meanwhile, the small blue shift observed with increasing DIO concentration indicated a more hydrophobic environment of the fluorescence chromophore of BSA [21]. Figures 2(b) and 2(c) showed that the fluorescence intensity decreased after adding Co²⁺ or Zn²⁺ with the same concentration. These indicated that the metal ions bind with BSA which is in accordance with our previous work. When DIO was added into BSA solution containing equimolar Co²⁺ or Zn²⁺, the fluorescence intensity decreased regularly with blue shift. The shapes of spectra were similar to those in the absence of Co²⁺ or Zn²⁺, while the fluorescence intensity in the presence of Co²⁺ or Zn²⁺ was weaker than those without Co²⁺ or Zn²⁺. The result obtained suggested that the fluorescence was quenched not only by the metal ions but also by DIO. The interaction occurred among BSA, DIO, and the metal ions.

(a)

(b)

(c)

3.2. The Quenching Mechanism and the Binding Constant

Fluorescence quenching is classified as dynamic quenching and static quenching. Usually, static quenching is due to the formation of ground-state complex between fluorophore and quencher. The static quenching constant will decrease with increasing temperature, because higher temperature will lower the stability of the complex. Dynamic quenching results from collision between fluorophore and quencher, as higher temperatures result in larger diffusion coefficients, so the reverse effect is observed [22–24].

To confirm the quenching mechanism, the fluorescence quenching data were analyzed according to the Stern-Volmer equation (1). The Stern-Volmer plots of different temperatures and the corresponding results were shown in Figure 3 and Table 1. The results showed that decreased with increasing temperature, and were much greater than 2.0 × 10¹⁰ L·mol⁻¹·s⁻¹, indicating a static quenching mechanism between BSA and DIO [25]. The quenching constants were both increased in the presence of Co²⁺ or Zn²⁺, indicating that the presence of Co²⁺ or Zn²⁺ increased the fluorescence quenching effect of DIO. Meanwhile, the values in the presence of Co²⁺ or Zn²⁺ suggest a static quenching mechanism for the binding of DIO to BSA with Co²⁺ or Zn²⁺.

(a)

(b)

In order to obtain the binding constants, the experimental data were also analyzed according to the modified Stern-Volmer equation (2). Figure 4 showed the modified Stern-Volmer plots at different temperatures, and the calculated binding constants for BSA-DIO system were listed in Table 2. The values for the binding of DIO with BSA were decreased with increasing temperature, which further suggested that the binding of DIO with BSA was static quenching. The binding constants for BSA-DIO system in the presence of Co²⁺ or Zn²⁺ were calculated to be 2.10 × 10⁵ L·mol⁻¹ and 1.94 × 10⁵ L·mol⁻¹, respectively. The binding constants for BSA-DIO system were both increased in the presence of Co²⁺ or Zn²⁺, implying stronger binding of DIO to BSA in the present of Co²⁺ or Zn²⁺.

(a)

(b)

3.3. The Nature of the Binding Forces

Generally, small organic molecules bound to biomolecules mainly through four types of acting forces: hydrogen bond, van der Waals' force, electrostatic force, and hydrophobic interaction, and so forth [26]. The force type can be determined by three thermodynamic parameters, enthalpy (), free-energy change (), and the entropy change (). These parameters for the interaction between DIO and BSA were calculated by Van’t Hoff equation (3) and thermodynamic equation (4). The Van’t Hoff plots were shown in Figure 5, and the thermodynamic parameters were listed in Table 2. The negative suggested that the reactions between DIO and BSA were spontaneous. DIO bound to BSA mainly through the hydrogen bond and Van der Waals’ force as evidenced by the negative value of and [27].

3.4. Energy Transfer between Drugs and BSA

The overlap of the absorption spectrum of DIO and the fluorescence emission spectrum of BSA is shown in Figure 6. For BSA, , , and [28]; then we can obtain the following results: cm³·L·mol⁻¹, nm, and nm. The distance between BSA and DIO was smaller than 8 nm, which suggested that the quenching of BSA by DIO was static quenching, which was in accordance with the results above.

3.5. The Binding of Site Maker Probes

There were two major binding sites for drugs on albumin which were known as Sudlow sites I and II. Site I is formed as a pocket in subdomain IIA and involves the lone tryptophan of the protein (²¹²Trp). Site I is adaptable and binds kinds of ligands with very different chemical structures. Site II locate at subdomain IIIA. It can bind smaller ligands because it is smaller, less flexible, and narrower than site I [29, 30]. Site I showed affinity for warfarin, ketoprofen, and so forth, and site II for ibuprofen, flufenamic acid, and so forth [31–33]. In order to determine the binding sites of DIO to BSA, the competitive displacement experiments were carried out using different site probes of ketoprofen for site I and ibuprofen for site II, respectively. The results showed that the binding constants of DIO to BSA were surprisingly changed from 2.57 to 1.304 × 10⁵ L·mol⁻¹ in the presence of ketoprofen, while the values almost remained the same in the case of ibuprofen (2.47 × 10⁵ L·mol⁻¹). The results indicated that ketoprofen exhibited significant displacement of DIO. However, ibuprofen was not displaced by DIO obviously. These meant that the binding site of DIO to BSA was site I.

3.6. Analysis of BSA Conformational Changes

Raman spectroscopy has emerged as a useful method to investigate the conformational changes of protein secondary structure and the microenvironment of amino acid residues [34]. In order to study the effects of DIO on the conformation of BSA, we analyzed the amide I and the regions of aromatic amino acid residues of Raman spectra. In Raman spectra, the peaks that appeared in the region of 1550–1620 cm⁻¹ were the ring vibration bands of aromatic residues [35]. The amide I band (1700–1630 cm⁻¹) originated mainly from peptide C=O stretching [36, 37]. Figure 7 displayed the Raman spectra of BSA and BSA-DIO system in the absence and presence of Co²⁺ and Zn²⁺. In the amide I band of BSA, the major band of BSA around 1648–1658 cm⁻¹ was the characterization of -helix; while the band of 1630–1640 cm⁻¹ represented short segment chains connecting the -helix, the bands of -turn were centered at 1680–1700 cm⁻¹, respectively [38–42]. Figure 8 was the curve fitting of Raman amide I; the corresponding results were listed in Table 3. The results showed that native BSA contains major -helix conformation (55.71%), which are consistent with the previous ones reported for BSA by Raman, infrared, and CD spectroscopy [43–45]. The -helix contents decreased to 47.58% due to the binding of DIO. Meanwhile, the content of -turn increased while the content of short segment decreased. The results indicated that the secondary structure of BSA was changed by DIO. Competing with the BSA-DIO system, the decreased extent of -helix content was lower in the presence of Zn²⁺, while for Co²⁺ there was an increase. The results indicated that the presence of Co²⁺ or Zn²⁺ affects the changes of BSA secondary structure.

(a)

(b)

(c)

(d)

The conformation of 17 disulphide bridges of serum albumin molecule can be sensitively determined by Raman spectroscopy. The disulphide bridges of BSA have three conformations: gauche-gauche-gauche (g-g-g, peaks around 510 cm⁻¹), gauche-gauche-trans or trans-gauche-gauche (g-g-t or t-g-g, peaks around 525 cm⁻¹), and trans-gauche-trans (t-g-t, peaks around 540 cm⁻¹) [46]. Figure 9 was the analysis of the S-S bands; the conformations of 17 disulphide bridges were obtained according to the fitting results. As shown in Table 4, the major conformation of disulphide bridges in native BSA was g-g-g conformations. After binding DIO, there were 7 S-S bridges converted conformations, while 3 conformations of S-S bridges were changed in the presence of Co²⁺ or Zn²⁺, which indicated the presence of Co²⁺ or Zn²⁺ decreased the changed of DIO to S-S bridges.

(a)

(b)

(c)

(d)

The tyrosyl doublet around 850 and 830 cm⁻¹, so-called “Fermi-resonance Tyr-doublet, was due to the symmetric ring-breathing vibration and the out-of-plane ring-bending vibration. The bands at 850 and 830 cm⁻¹ are extremely sensitive to hydrogen bonding of the phenolic OH-groups, and the intensity ratio of this doublet () is an indicator of the microenvironment of tyrosine residues. The value of this ratio between 0.3 and 0.5 indicated that the tyrosy1 residues were “buried.” On the other hand, the tyrosine residues were “exposed,” when the values range from 1.25 to 1.40 [47, 48]. The analysis of the Tyr side chains was displayed in Figure 10; the results in Table 5 showed that the value of decreased after the addition of DIO. But for BSA-DIO-Co²⁺ and BSA-DIO-Zn²⁺ systems were both increased in the presence of Co²⁺ or Zn²⁺, and the values were larger than that of free BSA. The results indicated that the buriedness of Tyr residues in protein was increased by DIO, but the presence of Co²⁺ or Zn²⁺ decreased the buriedness of Tyr residues [49].

(a)

(b)

(c)

(d)

The band appeared around 1340 cm⁻¹ and the weak shoulder around 1363 cm⁻¹ owing to the Fermi-resonance doublet bands of Trp residues. Their intensity ratio can also be used to investigate the overall hydrophobicity of the environment surrounding tryptophan residues [50, 51]. Figure 11 was the analysis of the Trp side chains; the results were listed in Table 5. The intensity ratio of increased from 0.0409 to 0.0461 due to the addition of DIO, while greater changes were found in BSA-DIO-Co²⁺ and BSA-DIO-Zn²⁺ systems. The results indicated that the hydrophobicity around the Trp residues increased due to the binding of DIO; the hydrophobicity increased more in the presence of Co²⁺ and Zn²⁺ [51].

(a)

(b)

(c)

(d)

4. Conclusions

In summary, we simulated the interaction of DIO with BSA in vitro by spectroscopic investigations. The experimental results indicated that the drugs could bind with BSA to form a DIO-BSA complex. The binding reaction was spontaneous. DIO bound to site I of BSA mainly through the hydrogen bond and Van der Waals’ force. The presence of Co²⁺ or Zn²⁺ increased the quenching effect and the binding affinity of DIO to BSA. Otherwise, the analysis of conformation change confirmed that the binding of DIO induced the unfolding of protein secondary structure. Although the changes of BSA secondary structure caused by DIO in the presence of Co²⁺ or Zn²⁺ were different from those without metal ions, they all major led to the decrease of -helix conformation. The addition of DIO changed 7 conformations of S-S bridges of BSA, while the changes were both reduced to 3 in the presence of Co²⁺ or Zn²⁺. Besides, DIO increased the buriedness of Tyr residues in protein, but the effects were opposite for BSA-DIO-Co²⁺ and BSA-DIO-Zn²⁺ systems. Meanwhile, the hydrophobicity around the tryptophan residues was all increased due to the binding of DIO in the absence and presence of Co²⁺ or Zn²⁺.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors gratefully acknowledge the National Natural Science Foundation of China (21061002, 21361003, and 21101035), the Scientific Research Foundation for the Returned overseas Chinese Scholars, the Guangxi Natural Science Foundation of China (2011GXNSFC018009, 2012GXNSFAA053035), Talent’s Small Highland project of Guangxi Medicinal Industry (1201), and the Foundation of Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources.

References

K. Higdon, A. Scott, M. Tucci et al., “The use of estrogen, dhea, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model,” Biomedical Sciences Instrumentation, vol. 37, pp. 281–286, 2001.
View at: Google Scholar
R. E. Temel, J. M. Brown, Y. Ma et al., “Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent,” Journal of Lipid Research, vol. 50, no. 5, pp. 915–923, 2009.
View at: Publisher Site | Google Scholar
T. Yamada, M. Hoshino, T. Hayakawa et al., “Dietary diosgenin attenuates subacute intestinal inflammation associated with indomethacin in rats,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 273, no. 2, pp. G355–G364, 1997.
View at: Google Scholar
K. L. G. Dias, N. D. A. Correia, K. K. G. Pereira et al., “Mechanisms involved in the vasodilator effect induced by diosgenin in rat superior mesenteric artery,” European Journal of Pharmacology, vol. 574, no. 2-3, pp. 172–178, 2007.
View at: Publisher Site | Google Scholar
Z. Yu, D. Li, B. Ji, and J. Chen, “Characterization of the binding of nevadensin to bovine serum albumin by optical spectroscopic technique,” Journal of Molecular Structure, vol. 889, no. 1–3, pp. 422–428, 2008.
View at: Publisher Site | Google Scholar
U. R. Chatterjee, S. Ray, V. Micard et al., “Interaction with bovine serum albumin of an anti-oxidative pectic arabinogalactan from Andrographis paniculata,” Carbohydrate Polymers, vol. 101, pp. 342–348, 2014.
View at: Google Scholar
X. Xu, L. Zhang, D. Shen, H. Wu, and Q. Liu, “Oxygen-dependent oxidation of Fe(II) to Fe(III) and interaction of Fe(III) with bovine serum albumin, leading to a hysteretic effect on the fluorescence of bovine serum albumin,” Journal of Fluorescence, vol. 18, no. 1, pp. 193–201, 2008.
View at: Publisher Site | Google Scholar
H. Liang, B. Xin, X. Wang, Y. Yuan, Y. Zhou, and P. Shen, “Equilibrium dialysis study on the interaction between Cu(II) and HSA or BSA,” Chinese Science Bulletin, vol. 43, no. 5, pp. 404–409, 1998.
View at: Google Scholar
H. Liang, J. Huang, C.-Q. Tu, M. Zhang, Y.-Q. Zhou, and P.-W. Shen, “The subsequent effect of interaction between Co²⁺ and human serum albumin or bovine serum albumin,” Journal of Inorganic Biochemistry, vol. 85, no. 2-3, pp. 167–171, 2001.
View at: Publisher Site | Google Scholar
S. M. T. Shaikh, J. Seetharamappa, P. B. Kandagal, and D. H. Manjunatha, “Antioxidant Chinese yam polysaccharides and its pro-proliferative effect on endometrial epithelial cells,” International Journal of Biological Macromolecules, vol. 41, no. 1, pp. 81–86, 2007.
View at: Publisher Site | Google Scholar
P. N. Naik, S. A. Chimatadar, and S. T. Nandibewoor, “Interaction between a potent corticosteroid drug—dexamethasone with bovine serum albumin and human serum albumin: a fluorescence quenching and fourier transformation infrared spectroscopy study,” Journal of Photochemistry and Photobiology B: Biology, vol. 100, no. 3, pp. 147–159, 2010.
View at: Publisher Site | Google Scholar
Y. Q. Wang, H. M. Zhang, G. C. Zhang, W. H. Tao, and S. H. Tang, “Binding of rare earth metal complexes with an ofloxacin derivative to bovine serum albumin and its effect on the conformation of protein,” Journal of Luminescence, vol. 126, pp. 211–218, 2007.
View at: Publisher Site | Google Scholar
Y. Ni, G. Liu, and S. Kokot, “Fluorescence spectrometric study on the interactions of isoprocarb and sodium 2-isopropylphenate with bovine serum albumin,” Talanta, vol. 76, no. 3, pp. 513–521, 2008.
View at: Publisher Site | Google Scholar
S. S. Lehrer, “Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion,” Biochemistry, vol. 10, no. 17, pp. 3254–3263, 1971.
View at: Google Scholar
W. He, Y. Li, C. Xue, Z. Hu, X. Chen, and F. Sheng, “Effect of Chinese medicine alpinetin on the structure of human serum albumin,” Bioorganic and Medicinal Chemistry, vol. 13, no. 5, pp. 1837–1845, 2005.
View at: Publisher Site | Google Scholar
T. Förster and O. Sinanoglu, Modern Quantum Chemistry, Academic Press, New York, NY,USA, 1966.
J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Plenum Press, New York, NY, USA, 1983.
W. D. Horrocks Jr. and A. Peter Snyder, “Measurement of distance between fluorescent amino acid residues and metal ion binding sites. Quantitation of energy transfer between tryptophan and terbium(III) or europium(III) in thermolysin,” Biochemical and Biophysical Research Communications, vol. 100, no. 1, pp. 111–117, 1981.
View at: Google Scholar
P. B. Kandagal, J. Seetharamappa, S. Ashoka, S. M. T. Shaikh, and D. H. Manjunatha, “Study of the interaction between doxepin hydrochloride and bovine serum albumin by spectroscopic techniques,” International Journal of Biological Macromolecules, vol. 39, no. 4-5, pp. 234–239, 2006.
View at: Publisher Site | Google Scholar
A. Sułkowska, M. Maciazek-Jurczyk, B. Bojko et al., “Competitive binding of phenylbutazone and colchicine to serum albumin in multidrug therapy: a spectroscopic study,” Journal of Molecular Structure, vol. 881, no. 1–3, pp. 97–106, 2008.
View at: Publisher Site | Google Scholar
T. Yuan, A. M. Weljie, and H. J. Vogel, “Tryptophan fluorescence quenching by methionine and selenomethionine residues of calmodulin: orientation of peptide and protein binding,” Biochemistry, vol. 37, no. 9, pp. 3187–3195, 1998.
View at: Publisher Site | Google Scholar
D. Ran, X. Wu, J. Zheng et al., “Study on the interaction between florasulam and bovine serum albumin,” Journal of Fluorescence, vol. 17, no. 6, pp. 721–726, 2007.
View at: Publisher Site | Google Scholar
M. Xu, F.-J. Chen, L. Huang, P.-X. Xi, and Z.-Z. Zeng, “Binding of rare earth metal complexes with an ofloxacin derivative to bovine serum albumin and its effect on the conformation of protein,” Journal of Luminescence, vol. 131, no. 8, pp. 1557–1565, 2011.
View at: Publisher Site | Google Scholar
J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Kluwer Academic/Plenum, New York, NY, USA, 2nd edition, 1999.
P. Banerjee, S. Pramanik, A. Sarkar, and S. C. Bhattacharya, “Deciphering the fluorescence resonance energy transfer signature of 3-pyrazolyl 2-pyrazoline in transport proteinous environment,” The Journal of Physical Chemistry B, vol. 113, no. 33, pp. 11429–11436, 2009.
View at: Publisher Site | Google Scholar
S. N. Timaseff, “Thermodynamics of protein interactions,” in Proteins of Biological Fluids, H. Peeters, Ed., pp. 511–519, Pergamon Press, Oxford, UK, 1972.
View at: Google Scholar
P. D. Ross and S. Subramanian, “Thermodynamics of protein association reactions: forces contributing to stability,” Biochemistry, vol. 20, no. 11, pp. 3096–3102, 1981.
View at: Google Scholar
X.-Z. Feng, Z. Lin, L.-J. Yang, C. Wang, and C.-L. Bai, “Investigation of the interaction between acridine orange and bovine serum albumin,” Talanta, vol. 47, no. 5, pp. 1223–1229, 1998.
View at: Publisher Site | Google Scholar
T. Peters, All about Albumin: Biochemistry, Genetics, and Medical Applications, Academic Press, San Diego, CA, USA, 1996.
U. Krach-Hansen, V. T. G. Chuang, and M. Otagiri, “Practical aspects of the ligand-binding and enzymatic properties of human serum albumin,” Biological and Pharmaceutical Bulletin, vol. 25, no. 6, pp. 695–704, 2002.
View at: Publisher Site | Google Scholar
C. E. Petersen, C.-E. Ha, S. Curry, and N. V. Bhagavan, “Probing the structure of the warfarin-binding site on human serum albumin using site-directed mutagenesis,” Proteins: Structure, Function and Genetics, vol. 47, no. 2, pp. 116–125, 2002.
View at: Publisher Site | Google Scholar
X. M. He and D. C. Carter, “Atomic structure and chemistry of human serum albumin,” Nature, vol. 358, no. 6383, pp. 209–215, 1992.
View at: Publisher Site | Google Scholar
H. Greige-Gerges, R. A. Khalil, E. A. Mansour, J. Magdalou, R. Chahine, and N. Ouaini, “Cucurbitacins from Ecballium elaterium juice increase the binding of bilirubin and ibuprofen to albumin in human plasma,” Chemico-Biological Interactions, vol. 169, no. 1, pp. 53–62, 2007.
View at: Publisher Site | Google Scholar
A. Misiunas, Z. Talaikyte, G. Niaura, V. Razumas, and T. Nylander, “Thermomyces lanuginosus lipase in the liquid-crystalline phases of aqueous phytantriol: X-ray diffraction and vibrational spectroscopic studies,” Biophysical Chemistry, vol. 134, no. 3, pp. 144–156, 2008.
View at: Publisher Site | Google Scholar
C. David, S. Foley, C. Mavon, and M. Enescu, “Reductive unfolding of serum albumins uncovered by Raman spectroscopy,” Biopolymers, vol. 89, no. 7, pp. 623–634, 2008.
View at: Publisher Site | Google Scholar
W. K. Surewicz, H. H. Mantsch, and D. Chapman, “Determination of protein secondary structure by fourier transform infrared spectroscopy: a critical assessment,” Biochemistry, vol. 32, no. 2, pp. 389–394, 1993.
View at: Google Scholar
A. I. Ivanov, E. A. Korolenko, E. V. Korolik et al., “Chronic liver and renal diseases differently affect structure of human serum albumin,” Archives of Biochemistry and Biophysics, vol. 408, no. 1, pp. 69–77, 2002.
View at: Publisher Site | Google Scholar
J. T. Pelton and L. R. McLean, “Spectroscopic methods for analysis of protein secondary structure,” Analytical Biochemistry, vol. 277, no. 2, pp. 167–176, 2000.
View at: Publisher Site | Google Scholar
B. M. Smith and S. Franzen, “Single-pass attenuated total reflection fourier transform infrared spectroscopy for the analysis of proteins in H₂O solution,” Analytical Chemistry, vol. 74, no. 16, pp. 4076–4080, 2002.
View at: Publisher Site | Google Scholar
J. Fontecha, J. Bellanato, and M. Juarez, “Infrared and Raman spectroscopic study of casein in cheese: effect of freezing and frozen storage,” Journal of Dairy Science, vol. 76, no. 11, pp. 3303–3309, 1993.
View at: Publisher Site | Google Scholar
H. Fabian and P. Anzenbacher, “New developments in Raman spectroscopy of biological systems,” Vibrational Spectroscopy, vol. 4, no. 2, pp. 125–148, 1993.
View at: Google Scholar
J. Wang, S. Li, X. L. Peng et al., “Multi-spectroscopic studies on the interaction of human serum albumin with astilbin: binding characteristics and structural analysis,” Journal of Luminescence, vol. 136, pp. 422–429, 2013.
View at: Publisher Site | Google Scholar
Q. Yang, J. Liang, and H. Han, “Probing the interaction of magnetic iron oxide nanoparticles with bovine serum albumin by spectroscopic techniques,” The Journal of Physical Chemistry B, vol. 113, no. 30, pp. 10454–10458, 2009.
View at: Publisher Site | Google Scholar
B. I. Baello, P. Pancoska, and T. A. Keiderling, “Enhanced prediction accuracy of protein secondary structure using hydrogen exchange fourier transform infrared spectroscopy,” Analytical Biochemistry, vol. 280, no. 1, pp. 46–57, 2000.
View at: Publisher Site | Google Scholar
D. Li, M. Zhu, C. Xu, and B. Ji, “Characterization of the baicalein-bovine serum albumin complex without or with Cu²⁺ or Fe³⁺ by spectroscopic approaches,” European Journal of Medicinal Chemistry, vol. 46, no. 2, pp. 588–599, 2011.
View at: Publisher Site | Google Scholar
H. E. Van Wart, A. Lewis, H. A. Scheraga, and F. D. Saeva, “Disulfide bond dihedral angles from Raman spectroscopy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 70, no. 9, pp. 2619–2623, 1973.
View at: Google Scholar
Z. Jurasekova, G. Marconi, S. Sanchez-Cortes, and A. Torreggiani, “Spectroscopic and molecular modeling studies on the binding of the flavonoid luteolin and human serum albumin,” Biopolymers, vol. 91, no. 11, pp. 917–927, 2009.
View at: Publisher Site | Google Scholar
P. R. Carey, Biochemical Applications of Raman and Resonance Raman Spectroscopics, Academic Press, New York, NY, USA, 1982.
N.-T. Yu, B. H. Jo, and D. C. O'Shea, “Laser Raman scattering of cobramine B, a basic protein from cobra venom,” Archives of Biochemistry and Biophysics, vol. 156, no. 1, pp. 71–76, 1973.
View at: Google Scholar
T. Miura, H. Takeuchi, and I. Harada, “Characterization of individual tryptophan side chains in proteins using Raman spectroscopy and hydrogen-deuterium exchange kinetics,” Biochemistry, vol. 27, no. 1, pp. 88–94, 1988.
View at: Google Scholar
I. Harada, T. Miura, and H. Takeuchi, “Origin of the doublet at 1360 and 1340 cm⁻¹ in the Raman spectra of tryptophan and related compounds,” Spectrochimica Acta A: Molecular Spectroscopy, vol. 42, no. 2-3, pp. 307–312, 1986.
View at: Google Scholar

Copyright

Copyright © 2014 He-Dong Bian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1750

Downloads

1008

Citations

Evidence-Based Complementary and Alternative Medicine

Chemical Basis of Traditional Medicines and New Potential Applications

The Spectroscopy Study of the Binding of an Active Ingredient of Dioscorea Species with Bovine Serum Albumin with or without Co2+ or Zn2+

Abstract

1. Introduction

2. Materials and Methods

2.1. Materials

2.2. Fluorescence Spectrum

2.2.1. The Quenching Mechanism

2.2.2. The Quenching Mechanism and the Binding Constant

2.2.3. Thermodynamic Parameters

2.2.4. Energy Transfer Calculation

2.3. Raman Spectrum

3. Results and Discussion

3.1. The Influence of DIO on the Fluorescence of BSA without or with Co2+ or Zn2+

3.2. The Quenching Mechanism and the Binding Constant

3.3. The Nature of the Binding Forces

3.4. Energy Transfer between Drugs and BSA

3.5. The Binding of Site Maker Probes

3.6. Analysis of BSA Conformational Changes

4. Conclusions

Conflict of Interests

Acknowledgments

References

Copyright

The Spectroscopy Study of the Binding of an Active Ingredient of Dioscorea Species with Bovine Serum Albumin with or without Co²⁺ or Zn²⁺

3.1. The Influence of DIO on the Fluorescence of BSA without or with Co²⁺ or Zn²⁺